News & Trends - MedTech & Diagnostics
Private hospitals’ high quality care recognised at APHA awards
A palliative care service offering patients support to die at home, a driving service that gets patients to and from their dialysis appointments and a mental health support program are all finalists in the APHA Awards For Excellence.
The Awards, to be presented at this year’s APHA 39th National Congress (APHA Congress) gala dinner, celebrate private hospital’s achievements in three categories: Clinical excellence, comprehensive care and consumer partnerships.
Australian Private Hospitals Association (APHA) CEO Michael Roff said the awards were developed to recognise the high quality of care Australians receive from private hospitals.
“The diversity in the entries for each category highlights the scope of care private hospitals provide. These are all innovative programs designed to improve patient’s experience and improve care or access to care,” he said.
Mr Roff said one of the great things to come out of these programs are the additional unintended benefits for patients.
“The Epworth Eastern’s program of volunteers driving renal dialysis patients to their appointments and home again has not only made it easier for patients to get care, but also created new friendships and broken the social isolation that often comes from having a serious illness and challenges in accessing transport.
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
“Another is South Australia’s St Andrew’s Hospital’s critical bleeding working group, a program set up to improve timely administration of blood for patients requiring massive transfusions. Not only has this led to reduced wastage of blood products but the group also developed a purpose-built Massive Transfusion Shipper now used by the South Australian Ambulance Service.
“These programs illustrate the patient-focus of our private hospitals, and it is important to celebrate those successes,” he said.
Attendees at the APHA Congress will have a role to play in determining the winners. Finalists will present their work during a session at the APHA Congress and delegates will vote for the best entries. The delegate vote accounts for five percent of the final score.
Winners will be announced on Monday 16 March 2020 in Adelaide.
Awards finalists
Clinical excellence – quality of care and patient outcomes
- Sydney Adventist Hospital: San community palliative care service
- Ramsay Health Care: Ramsay national mental health programs
- St Andrews Hospital: Critical bleeding working group
Comprehensive care
- Epworth Eastern: Renal dialysis patient transport vehicle program
- Friendly Society Private Hospital: Culture of accountability
Consumer partnerships
- Bethesda Health Care: Consumer partnership committee
- Westmead Private Hospital: Luxury maternity unit
Suppliers & Service Providers: Enhance business visibility, differentiate your brand and maximise your reach. Health Industry Hub is the only one-stop-hub connecting your business to Australia’s Pharma, MedTech, and Biotech industry professionals. Discover our unique digital media solutions with superior open rates and click through rates.
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More